Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,290 | 15 | 44.3% |
| Consulting Fee | $875.00 | 1 | 30.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $743.17 | 1 | 25.5% |
| Education | $2.09 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure Inc. | $1,191 | 12 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $907.16 | 4 | $0 (2017) |
| F. Hoffmann-La Roche AG | $743.17 | 1 | $0 (2018) |
| Novocure Israel Ltd | $68.65 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $122.15 | 1 | Novocure Inc. ($122.15) |
| 2022 | $185.37 | 2 | Novocure Inc. ($185.37) |
| 2021 | $235.09 | 2 | Novocure Inc. ($235.09) |
| 2019 | $114.59 | 1 | Novocure Inc. ($114.59) |
| 2018 | $926.17 | 3 | F. Hoffmann-La Roche AG ($743.17) |
| 2017 | $1,326 | 9 | E.R. Squibb & Sons, L.L.C. ($907.16) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $122.15 | General |
| Category: Oncology | ||||||
| 11/18/2022 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $89.09 | General |
| Category: Oncology | ||||||
| 03/09/2022 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $96.28 | General |
| Category: Oncology | ||||||
| 11/18/2021 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $136.41 | General |
| Category: Oncology | ||||||
| 03/10/2021 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $98.68 | General |
| Category: Oncology | ||||||
| 06/01/2019 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $114.59 | General |
| Category: Optune | ||||||
| 10/13/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $89.29 | General |
| Category: Optune | ||||||
| 09/30/2018 | F. Hoffmann-La Roche AG | TECENTRIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $743.17 | General |
| Category: BioOncology | ||||||
| 06/02/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $93.71 | General |
| Category: Optune | ||||||
| 11/16/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $37.77 | General |
| Category: Oncology | ||||||
| 07/19/2017 | Novocure Israel Ltd | Optune (Device) | Food and Beverage | Cash or cash equivalent | $68.65 | General |
| Category: Oncology | ||||||
| 07/19/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $68.65 | General |
| Category: Oncology | ||||||
| 06/03/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $99.69 | General |
| Category: Oncology | ||||||
| 05/25/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| Category: Oncology | ||||||
| 05/05/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $144.47 | General |
| Category: Oncology | ||||||
| 05/05/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $25.88 | General |
| Category: Oncology | ||||||
| 05/05/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $4.19 | General |
| Category: Oncology | ||||||
| 05/05/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $2.09 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 340 | 475 | $196,110 | $43,115 |
| 2022 | 9 | 318 | 457 | $180,630 | $40,324 |
| 2021 | 10 | 448 | 620 | $251,985 | $59,155 |
| 2020 | 9 | 388 | 494 | $194,710 | $39,633 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 135 | 202 | $75,750 | $15,663 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 60 | 111 | $55,160 | $13,155 | 23.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 44 | $20,680 | $4,842 | 23.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $15,070 | $3,225 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 42 | 50 | $12,750 | $2,677 | 21.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 21 | $5,250 | $1,404 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $6,900 | $1,233 | 17.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $4,550 | $914.42 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 131 | 197 | $73,875 | $15,685 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 47 | 84 | $41,580 | $10,155 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 41 | 52 | $13,260 | $2,818 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 21 | 21 | $12,075 | $2,414 | 20.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $10,650 | $2,342 | 22.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $9,400 | $2,275 | 24.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $9,590 | $2,244 | 23.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 24 | $6,000 | $1,437 | 24.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 30 | $4,200 | $954.14 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 147 | 214 | $80,250 | $17,745 | 22.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 78 | 135 | $66,825 | $16,899 | 25.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 45 | 45 | $21,150 | $5,205 | 24.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 30 | 30 | $20,550 | $5,110 | 24.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 25 | 25 | $17,750 | $3,860 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 35 | 46 | $11,500 | $2,812 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 43 | 49 | $12,495 | $2,680 | 21.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 20 | $7,100 | $1,757 | 24.7% |
About Dr. Joachim Baehring, MD
Dr. Joachim Baehring, MD is a Neurology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982686622.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joachim Baehring, MD has received a total of $2,910 in payments from pharmaceutical and medical device companies, with $122.15 received in 2023. These payments were reported across 18 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($1,290).
As a Medicare-enrolled provider, Baehring has provided services to 1,494 Medicare beneficiaries, totaling 2,046 services with total Medicare billing of $182,227. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location New Haven, CT
- Active Since 11/17/2005
- Last Updated 12/14/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1982686622
Products in Payments
- Optune (Device) $961.84
- OPDIVO (Biological) $907.16
- TECENTRIQ (Biological) $743.17
- Oncology (Device) $297.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in New Haven
Sharon Stoll, D.o, D.O
Neurology — Payments: $782,631
Dr. David Russell, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $390,295
Dr. Kenneth Marek, Md, MD
Neurology — Payments: $293,594
David Hafler, Md, MD
Neurology — Payments: $133,003
Stephen Waxman, Md, MD
Neurology — Payments: $125,575
Imran Quraishi, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $107,014